Published in
Taylor and Francis Group, HIV Clinical Trials, 5(14), p. 204-215
DOI: 10.1310/hct1403-204
Taylor and Francis Group, HIV Clinical Trials, 5(14), p. 204-215
DOI: 10.1310/hct1405-204
Links
Tools
Safety, Efficacy, and Persistence of Emtricitabine/Tenofovir Versus Other Nucleoside Analogues in Naive Subjects Aged 50 Years or Older in Spain: The TRIP Study
Journal article published in 2013 by
Ana María Caro-Murillo,
José Ramón Blanco,
Manuel Angel Castaño,
Julián Olalla,
Pere Domingo,
Juan Luis Gómez-Sirvent,
Piedad Arazo,
Melchor Riera,
Federico Pulido 
,
Francisco Vera,
Alberto Romero-Palacios,
Koldo Aguirrebengoa,
Joaquín Portilla,
Pedro Ferrer,
Enric Pedrol
,
Francisco Vera,
Alberto Romero-Palacios,
Koldo Aguirrebengoa,
Joaquín Portilla,
Pedro Ferrer,
Enric Pedrol
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 